Skip to main content
Clinical Trials/ISRCTN18026662
ISRCTN18026662
Completed
N/A

School-based educational and on-site vaccination intervention for the prevention of MMR and Tdap-IPV among adolescents

Federal Ministery of Health (BMG)0 sites510 target enrollmentDecember 5, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
MMR vaccine (Measles, Mumps, Rubella) Tdap-IPV vaccine (Tetanus, Diphteria, Pertussis, Polio)
Sponsor
Federal Ministery of Health (BMG)
Enrollment
510
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30700487 protocol (added 24/02/2020) 2022 Interim results article in https://pubmed.ncbi.nlm.nih.gov/35012511/ pilot study results (added 25/10/2022)

Registry
who.int
Start Date
December 5, 2017
End Date
August 31, 2018
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Federal Ministery of Health (BMG)

Eligibility Criteria

Inclusion Criteria

  • School level:
  • 1\. Centric boroughs within circle line (Ringbahn \- public Transport Berlin)
  • 2\. Summed minimum number of pupils in potential School classes: 230
  • Participant level:
  • 1\. Age (\>15 years)
  • 2\. Signed informed consent by the parents

Exclusion Criteria

  • Under 15 years of age

Outcomes

Primary Outcomes

Not specified

Similar Trials